科微学术

微生物学通报

布鲁氏菌LS蛋白(BLS)研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家重点研发计划(2017YFD0500905,2016YFD0500902)


Research progress in Brucella lumazine synthase (BLS)
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    LS蛋白(2,4-二氧四氢蝶啶合成酶)广泛存在于动物、植物和微生物中,是催化核黄素生物合成的重要合成酶之一。该酶最显著的特征之一是其在不同物种中具有空间结构差异。布鲁氏菌LS蛋白(BLS)是布鲁氏菌的一种优势抗原,是由两个五聚体组成的结构稳定的十聚体。BLS是光滑型和粗糙型布鲁氏菌所共有的抗原,用于布鲁氏菌病的诊断可提高其敏感性;BLS可以激发抗原特异性细胞应答产生IFN-γ,从而对宿主产生保护力,是一种理想的布鲁氏菌病亚单位疫苗的候选蛋白。本文综述了BLS的结构特性及应用研究进展,旨在为BLS的深入研究和开发应用提供参考。

    Abstract:

    Lumazine synthase (LS) is widely distributed in animals, plants and microbes, and is one of the important synthesizing enzymes that catalyze the biosynthesis of riboflavin. One of the most remarkable characteristics of LS is that it has different spatial structures in different species. Brucella lumazine synthase (BLS), which has a stable structure of decamer consisting of two pentamers, is a dominant antigen of Brucella. BLS is a common antigen existing in both smooth type and rough type Brucella, and it can improve the sensitivity of diagnostic assays for Brucellosis; BLS is capable of stimulating antigen-specific cellular responses, resulting in production of IFN-γ, which consequently provides protection for the host. Therefore, BLS is an ideal candidate protein for development of subunit vaccine against Brucellosis. In this paper, the structural features of BLS protein and its application are reviewed, aiming at providing reference for in-depth studies and application of BLS.

    参考文献
    相似文献
    引证文献
引用本文

孙佳丽,彭小薇,孙石静,袁维峰,丁家波. 布鲁氏菌LS蛋白(BLS)研究进展[J]. 微生物学通报, 2019, 46(5): 1179-1184

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-04-30
  • 出版日期:
文章二维码